CISORDINOL

This brand name is authorized in Austria, Estonia, Finland, Lithuania, Malta, Netherlands.

Active ingredients

The drug CISORDINOL contains one active pharmaceutical ingredient (API):

1
UNII 7042692VYN - ZUCLOPENTHIXOL HYDROCHLORIDE
 

Zuclopenthixol is a potent neuroleptic of the thioxanthene series with a piperazine side-chain. The antipsychotic effect of neuroleptics is related to their dopamine receptor blocking effect.
 
Read more about Zuclopenthixol

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
N05AF05 Zuclopenthixol N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AF Thioxanthene derivatives
Discover more medicines within N05AF05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
EE Ravimiamet 1005781, 1005815, 1006232, 1006322, 1065226
FI Lääkealan turvallisuus- ja kehittämiskeskus 011353, 140442, 509034, 509042, 545814, 545848, 545871
LT Valstybinė vaistų kontrolės tarnyba 1002966, 1002970, 1005443
MT Medicines Authority AA565/82601, AA565/82602
NL Z-Index G-Standaard 12149217, 12353973, 13295497, 13529978
NL Z-Index G-Standaard, PRK 17647, 17655, 17663, 17671, 27391, 29831, 7331

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈